EFTA02595375.pdf

From: Misha Gromov Sent: Monday, October 2, 2017 3:14 PM To: jeffrey E. Subject: Fwd: Arnold J. Levine, Adventures in Cancer Immunotherapy: The Role of the Immune System in Cancer Therapy Original Message Subject: Arnold J. Levine, Adventures in Cancer Immunotherapy: The Role of the Immune System in Cancer Therapy Date: Mon, 2 Oct 2017 11:11:56 -0400 EDT From: Simons Foundation Lectures To Reply-To: Having trouble viewing this email? Click here [1] [2] 131 ADVENTURES IN CANCER IMMUNOTHERAPY: THE ROLE OF THE IMMUNE SYSTEM IN CANCER THERAPY Life Sciences Speaker: Arnold J. Levine Wednesday, October 4, 2017 4:15PM Tea; 5:00PM Lecture Add to Calendar [4] [5] In the 1960s, Lewis Thomas postulated that cancer cells in the body expressed foreign antigens. The human immune system, he proposed, recognized these antigens and killed the cancer cells. The next forty years saw a largely fruitless search for cancer-produced antigens recognized by killer T cells. Finally, researchers discovered that although cancer cells are recognized by the immune system, the cells acquired a set of proteins that protected against killer T cells. In these cases, tumors exhibit a "self-tolerance." Certain antibodies can block the functionality of these self-tolerizing proteins, permitting T cells to kill the tumor cells. As potential therapies using this technique were explored, a number of complicated problems arose. This therapy worked with some tumor types, but not others. Even for the same tumor type, some cancers responded to this therapy, while others did not. In this lecture, Arnold Levine will discuss how recent studies have illuminated a great deal about the human immune system and its complexities. Methods for sequencing T cell receptors and quantifying their diversity have been developed. Antigens recognized by these T cell receptors can be identified by matching amino acid sequences to mutations in the DNA sequences of cancers and the microbiome. Algorithms are being developed to identify responders and non-responders, identify tumor antigens and explore the vitality and functionality of the immune system. EFTA_R1_01779981 EFTA02595375 These studies have elucidated a great deal about the complexities of the human immune system, but this area of research has just begun. Levine [6] is an acclaimed leader in cancer research. In 1979, Levine and others discovered the p53 tumor suppressor protein, a molecule that inhibits tumor development. He established the Simons Center for Systems Biology at the Institute for Advanced Study in Princeton, New Jersey, which concentrates on research at the interface of molecular biology and the physical sciences. Such focuses include genetics and genomics; polymorphisms and molecular aspects of evolution; signal transduction pathways and networks; stress responses; and pharmacogenomics in cancer biology. Limited seating is available on a first-come, first-served basis. Without registration, you will not be informed of scheduling changes. If you have already registered but are are no longer able to attend, please notify [email protected] [7]. The attached flyer [8] can be shared with your colleagues. (91 Gerald D. Fischbach Auditorium Simons Foundation 160 Fifth Avenue at 21st Street, 2nd Floor New York, NY 10010 Inquiries: [10] Simons Foundation Lectures calendar [11] Directions [12] Follow us on Twitter [13] [14] [15] Copyright 2016. All Rights Reserved. Update Profile/Email Address [16] [ SafeUnsubscribe (17](tm) I Privacy Policy [18]. Simons Foundation Lectures [ 160 Fifth Avenue at 21st Street 12nd floor [ New York I NY 10010 Links: [1] http://campaign.r20.constantcontact.com/render?m=1117618064332&ca=0567a0b6-587b-4385-b7f6-b6074bbb27e9 [2] http://r20.rs6.net/tn.jsp?f=001TvEUUiEHKxlrOPIEn76Dk2xMOR_JHZ7loCYN4d8PaAHRvI2ir8x8lAiwFPDTi_h4nUwd3Vh5LY byo3loCcUTdW8S4UizCfSdWM7pIn0ZDX5Ok8oGjl2MXcgoy0j6i-R132OBLsiXUuGqlsX6Hz- y9_k4S20xqivLUm5kLM2xh0g3qQlsg7ZJXNFORsIngBV-eWBEI- RDIlk=&c=VkQmP00r8Sammx2F9EvizX9G9cPNQmevsgOx8oM7s2zcK2PxQRppA==&ch=kuFlWiWL8DeFIVvprTf31ERnf27K tjagtMp3asysc8Kyp3hugtV7FQ== (3] http://r20.rs6.net/tn.jsp?f=001TvEUUiEH KxlrOPIEn76Dk2xMCle_JHZ7loCYN4dBPaAHRvIZir8x8INaQwWV3AG_drDqOVSm O5g6E6j7AeCMkF4q-dBrcZDID3ku6eHYW-h6K_pcMtWFbpgvRkVyDOzrPsNTyNVSuP- ODcrjQvydXza6ksos0RERfxyDKBUrO0IxX_c2SBzxWGIZih2- YK46v&c=VkQmP0fJr8SammxZF9EvizX9G9cPNQmevsgOx8oM7s2zcK2PxQRppA==&ch=kuFIWiWL8DeFIVvprTf31ERnf27Kt jagtMp3asysc8Kyp3hugtV7FQ== [4] 2 EFTA_R1_01779982 EFTA02595376 http://r20.rs6.net/tn.jsp?f=001TvEUUiEHKxlrOPIEn76Dk2xMCieJHZ7loCYN4dBPaAHRvIZir8x8ICQ9gcwBAKNVKzmbR48 mGPeNCILYPoc6Z1WvoF7gr3rr0E4qgUrBNaYWdGtxgVWjjlqIc5Y_mWpCOLGmtplVk5FD8cV2jMX5pqjq4uDs5i0qA0IZ1DR lvlujKQgcTMWhPGBQb9D3bw26nbEt0SibBy- b9WrFGZMxalL6UupF495pU3IYhJ02xUd0KcnahiGJ0RCact7F4o7WM_ZccUh71V0=&c=VkQmP00r8Sammx2F9EvizX9G9cP Niamevsg0x8oM7s2zcK2PxClRppA==&ch=kuFIWIWL8DeFIVvprTf31ERnfZ7KtjagtMp3asysc8Kyp3hugtV7FQ== [5] http://events.r20.constantcontact.com/register/eventReg?oeidk=a07eel9pbar5lfbb8ea&c=30cea330-07ae-lle4-9a82- d4ae5275509e&ch=31d25790-07ae-11e4-9b4c-d4ae5275509e [6] http://r20.rs6.net/tn.jsp?f=001TvEUUIEHKxlrOPIEn76Dk2xMCIeJHZ7loCYN4dBPaAHRvIZir8x8INaQwWV3AG_drDq0VSm O5g6E6j7AeCMkF4q-dBrcZDID3ku6eHYW-h6K_pcMtWFbpgvRkVyDOzrPsNTyNVSuP- ODcrjQvydXza6ksosORERfxyDKBUrO0IxX_c2SBzxWGIZih2- YK46v&c=VkQmPOfJr8SammxZF9EvizX9G9cPNQmevsgOx8oM7s2zcK2PxQRppA==&ch=kuFIWiWL8DeFIVvprTf31ERnfZ7Kt jagtMp3asysc8Kyp3hugtV7FQ== [7] mailto:[email protected] [8] http://r20.rs6.net/tn.jsp?f=001TvEUUIEHKxlrOPIEn76Dk2xMCIeJHZ7loCYN4dBPaAHRvIZir8x8ICQ9gcwL3AKNyftL38dRkh 900julyaFHTZrOcux9vd8jRsCshn97WMI6rN_08tTL3EyObJ8mv9koefBwPv7.InC-1Yd3gWnljgRiQl- lzDDYle6_KVnnc7BwTeESxaOrKVRkgnxzz27E7Lo78MW4fXixiGnRkKDOdnmw8jU3pDCA3F4QSCGFVW2c7MOwLpqCzp5Z7 OVGjnS3N&c=VkQmPOOr8Sammx2F9EvizX9G9cPNQmevsg0x8oM7s22cK2PxQRppA==&ch=kuFIWIWL8DeFIVvprTf31ERnf Z7KtjagtMp3asysc8Kyp3hugtV7FQ== [9] http://r20.rs6.net/tn.jsp?f=001TvEUUIEHKxlrOPIEn76Dk2xMO.e_JHZ7loCYN4dESPaAHRvIZir8x8I0AIKRfrd_ubvbG4N4QoN RjkMsqdGA91I9gL3jEGvwC3GNxHXyhNyi7s_KUHHVOx5dPjlu3dxp_VWFloCAGJJBW92nulc8F8FLP7c5D4RMHTMTZ3ZM_v eARFgsTuNX5r7Fyv8- 100p2V&c=VkQmPOLIr8Sammx2F9EvizX9G9cPNQmevsg0x8oM7s2zcK2PKIRppA==&ch=kuFIWiWL8DeFIVvprTf31ERnfZ 7KtjagtMp3asysc8Kyp3hugtV7FQ== [10] mailto:[email protected] [11] http://r20.rs6.net/tn.jsp?f=001TvEUUIEHKxlrOPIEn76Dk2xMCIeJHZ7loCYN4dBPaAHRvIZir8x8IGACGVgY.IxpOATUKeciRNz vIL51sWAWw4rBvOD7unKdHBAXCkTLbU4yc_5g1KCZSRRTAGSBOQkBaVUPHoTMJ4TBHOXWP6n5wRH1DRR6PNJHRPvQes HtnN2Muf6BG_g_Ye76TV5SBoQA8WqYe8OXy5g=&c=VkQmPOUr8Sammx2F9EvizX9G9cPNQmevsg0x8oM7s2zcK2PxQRp pA==&ch=kuFlWiWL8DeFIVvprTf31ERM27KtjagtMp3asysc8Kyp3hugtV7FQ== [12] http://r20.rs6.net/tn.jsp?f=001TvEUUIEHKxlrOPIEn760k2xMORJHZ7loCYN4dElPaAHRvIZir8x8LIMsVaKk3meZglOw6ICLW f_hirHOuJ6B7qIXBy9yEmS5t_AOOqZO-VE6T3uIgNg4Z162qafI_srXkMqdHL6BJ5HDe- OXL3mUWupIvemfjCLWnhxcUcm6yFzONVourKrTiVfQwJOQPapgYoYMfvRFwCbOvMbjEMPxhNLhIXf5o9r_Wx3QIkuAOj3wg g2Wtrpfo6CxjgyNqQwxc21kpKVSwku8jWD5xhq7TLyK2TDwDkNgd80m6g6jVSMOkXcPT_pGjxe5Hal8EML2GqzE4xawk- IVBuf7BZXdE9HmCUFsWjT4_543zFE0EqHl-fghB- QXG5xeVdwoxiFWvm2HVh9HDToU5YdFIRqxtRdUbIS2tAh4twCL1gEoAp1ogH2DDx2dm2WHCp0fH6uyOn.IRjfTWOhXUr6V WkEhC37uRdPOylwDqlFvLT1WZA7ZEPV45MvAh4n- fpsNvLHASAr6UBnfDcXANSFquG8LYyYKx560EGGsRJ_rpiHt3Hhea72dIv2eDjW7_2wPthbpk- eFbjlaFXvQsASAFOu36sDYQgAnCogC7xhz0FX2Y=&c=VkQmP0fir8Sammx2F9EvizX9G9cPNQmevsg0x8oM7s2zcK2PxQR ppA==8,tch=kuFIWIWL8DeFIVvprTf31ERnfZ7KtjagtMp3asysc8Kyp3hugtV7FQ== [13] http://r20.rs6.net/tn.jsp?f=001TvEUUiEH KxlrOPIEn76Dk2xMCle HZ7loCYN4dESPaAHRvIZir8x8IBhsm p0.xvm- rrZF_F6969Si6d_Stvb6wM6kPninsm-mz61MC5Ro- la Plvq46d4azQ2BldZNJPhYPeWbgla Lm MG12BflFhtfz0bUODIz6109sc4ZxCDiluzZDhR05EcqA==&c=VkQmPOfJr8SammxZ F9EvizX9G9cPNQmevsg0x8oM7s2zcK2PxQRppik==&ch=kuFIWIWL8DeFIVvprTf31ERnfZ7KtjagtMp3asysc8Kyp3hugtV7FQ [14] http://visitor.r20.constantcontact.com/email.jsp?m=1117618064332 [15] 3 EFTA_R1_01779983 EFTA02595377 http://ui.constantcontact.com/sa/fwtf.jsp?m=1117618064332&a=1128999754992&ea=gromovVO40ihes.fr [161 https://visitor.constantcontact.com/do?p=oo&m=001oETijuydVZKn56i_H4U8Bw%3D%3D&ch=31d25790-07ae-lle4- 9b4c-d4ae5275509e&ca=0567a0b6-587b-4385-b7f6-b6074bbb27e9 [171 https://visitor.constantcontact.com/do?p=un&m=001oETijuydVZKn56i_H4U8Bw%3D%3D8cch=31d25790-07ae-lle4- 9b4c-d4ae5275509e&ca=0567a0b6-587b-4385-b7f6-b6074bbb27e9 http://www.constantcontact.comfiegal/service-provider?cc=about-service-provider <?xml version="1.0" encoding="UTF-8"?> <IDOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/Propertylist-1.0.dtd"> <plist version="1.0"> <clict> <key>conversation-id</key> <integer>29208</integer> <key>date-last-viewed</key> <integer>0</integer> <key>date-received</key> <integer>1506957270</integer> <key>flags</key> <integer>8590195713</integer> <key>gmail-label-ids</key> <array> <integer>6</integer> <integer>2</integer> </array> <key>remote-id</key> <string>755162</string> </dict> </plist> 4 EFTA_R1_01779984 EFTA02595378